ONK Therapeutics Appoints Hugh O’Dowd as Independent Chairman

ONK Therapeutics Ltd, an innovative natural killer (NK) cell therapy company, today announced that it has appointed Hugh ODowd as Director and independent Non-executive Chairman of its Board of Directors.